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Abstract  
Antibiotic susceptibility discs are used for vitro susceptibility testing of antimicrobial agents to fast growing 
bacteria and fastidious species by agar diffusion method. It is a semi quantitative method. This study was 
designed to assess the efficacy of commercial antibiotic discs over in-house prepared discs. Identified 
clinical isolates were obtained in house in the Department of Medical Microbiology/Parasitology, 
University of Calabar Teaching Hospital, Nigeria. Staphylococcus aureus (ATCC 7553) and Escherichia 
Coli (ATCC 25922) were obtained and used as controls. The antibiotics tested includes; Ciprofloxacin, 
Erythromycin, Amoxicillin, Gentamicin, Zinacef.  These were obtained commercially from Pharmacy 
shops. The local antibiotic dics were prepared with Whatman filter paper number 3. The antibiotic 
susceptibility testing was done using Kirby-Bauer method. Out of the 40 clinical isolates tested, 15(37.5%) 
were Staphylococcus aureus while 10(12.5%) each were Escherichia coli and Pseudomonas aeruginosa 
respectively. Only 5 isolates of Proteus vulgaris were used. The susceptibility profile of isolates to the 
commonly used local antibiotic discs ranged between 66.7% to 100%, while the range for commercial 
discs was 53.3% to 86.7%. Locally prepared discs were found to be more effective than commercial 
discs. The high resistance rates (0.0% to 33.3%) of clinical isolates to the commercial discs may be 
attributed to prolong exposure to environmental factors such as heat, moisture, sunlight as well as 
humidity when transported to retailers and the final users. There is need for constant monitoring and 
quality controls of susceptibility testing in our laboratories for the production of quality results and efficient 
patient care. Antibiotic susceptibility discs can be prepared locally for routine laboratory use; this may 
indirectly reduce importation of commercial discs and the burden on foreign exchange. 
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Background of Study 
Antibiotics are substances produced by microorganisms that inhibits the growth 
of other microorganisms or kill the organisms. They are sometime called Antibacterial or 
Antimicrobials [1]. The indiscriminate and irrational use of antibiotics and other reasons 
have led to a global challenge of antimicrobial resistance [2]. Antimicrobial discs should 
be manufactured under strict compliance to standard operative procedures, otherwise, 
quality and performance standards will be compromised [5]. The standard procedures 
may not be met in the developing countries ompared to developed countries [6]. 
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Antibacterial discs commercially available in Nigeria may not contain the required 
quantity of active ingredients. This picture may be seen in many developing countries. 
Factors to be considered in the manufacturing and successful use of antibiotic discs 
include: quality of antibiotics, the composition of the discs, test performance, etc [8]. Eze 
et al [9] in South Eastern Nigeria reported that commercial antibiotic discs used in their 
locality were made of different paper quality. They observed high rates of differences in 
the diameters of the disc-papers, water absorbabilities, thicknesses and weights in all 
brands of antibiotic discs evaluated. 
The locally prepared antibiotic discs are readily available for use and are also 
cost effective. They seem to be more potent because they are prepared at the point of 
use, not exposed to excessive heat during transportation to the various retail outlets 
[10]. Locally prepared antibiotics are preferred because, it saves time, money, cost of 
transportation and delay when compared to the commercially prepared disc which is not 
readily available. The study was carried out to assess the potency of commercial 
antibiotic discs over locally prepared discs and to compare the potency of antibiotics 
disc from different manufacturers. 
 
METHODS 
Study Setting 
This research was carried out in the Microbiology/Parasitology Laboratory of the 
University of Calabar Teaching Hospital, Calabar, Cross River State. 
Source of bacterial isolates and antibiotics 
Identified clinical isolates were obtained in house in the same Department. 
Escherichia Coli (ATCC 25922) and Staphylococcus aureus (ATCC 7553) were 
obtained commercially and used as controls. The antibiotics tested includes; 
Ciprofloxacin, Erythromycin, Amoxicillin, Gentamicin, Zinacef.  These were obtained 
commercially from Pharmacy shops. 
 
Preparation of Antibiotic Discs 
 
Whatman filter paper grade 3 was used. The whatman paper discs of 6mm in 
diameter were punched and sterilized. Codes and the concentration of the antibiotics 
were printed on each filter paper disc [4]. Antibiotic stock solutions were prepared with 
known concentrations of the antibiotic powder in sterile distilled water. The stock 
solution was stored in the refrigerator. It was diluted to a required concentration of 
working solution thereafter. The discs were impregnated with 0.01µl of the working 
solution of antibiotics using automatic pipette. impregnated discs were dried in an 
incubator at 37°C and stored in small ampoules with a desiccant at minus 20 °C [4,6]. 
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Antibiotic Susceptibility Testing 
Antibiotic susceptibility testing was determined by the Kirby-Bauer disc diffusion 
method on Muller Hinton agar, and interpreted according to the recommendations of the 
Clinical Laboratory Standards Institute The antibiotic disc was applied using a sterile 
forceps and sufficiently separated from each other in other to prevent overlapping of the 
zone of inhibition. The plates were incubated at 370C for 18-24hours. The zone of 
inhibition was measured with a meter rule and it was compared with the Clinical 
Laboratory Standards Institute (CLSI) interpretive guide for antimicrobial susceptibility 
testing [11-12]. 
 
 
Data Analysis 
Data were analyzed using Epi Info 2012 (CDC, Atlanta, Georgia, USA) statistical 
software. Descriptive statistics were carried out. Frequencies were calculated for 
categorical variables. Interactions between specific categorical clinical variables were 
tested for significance using the χ2 test. A p-value of ≤0.05 was considered statistically 
significant. 
 
RESULTS 
Figure 1 shows the distribution of clinical isolates used in comparing the efficacy 
of locally prepared antibiotic discs with commercial discs. Out of the 40 clinical isolates 
used 15(37.5%) were Staphylococcus aureus while 10(12.5%) isolates each were 
Escherichia coli and Pseudomonas aeruginosa. Only 5 isolates of Proteus Vulgaris 
were used.  
 
 
Fig. 1 Distribution of clinical isolates used for antibiotic susceptibility testing 
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Table 1 shows the susceptibility rate of clinical isolates to locally prepared 
antibiotic discs. The susceptibility profile of isolates to the commonly used local 
antibiotic discs ranged between 66.7% to 100%. Staphylococcus aureus susceptibility 
profile range between 66.7% - 93.3%. The organism was most susceptible to 
Erythromicin 93.3%, followed by Fortum 86.7%. The lowest susceptibility 66.7% was 
observed on ciprofloxacin and Ceftriaxone respectively. 
Escherichia coli susceptibility profile range between 80.0% - 90.0%. The highest 
susceptibility rate 90.0% was observed in Gentamicin while other three antibiotics 
showed 80.0% susceptibility (Table 1). Pseudomonas aeruginosa susceptibility profile 
for local discs range between 70.0% - 100%. It was most susceptible to Fortum, while 
the lowest susceptibility (70.0%) was observed in Gentamycin. Proteus vulgaris was 
most susceptible to Ceftriaxone (100%) and least susceptible to gentamicin (60.0%) 
(Table 1). 
Table 2 shows the susceptibility rate of clinical isolates to commercial antibiotic 
discs. The susceptibility profile of clinical isolates to the commonly used commercial 
discs ranged between 53.3% to 86.7%. Erythromycin was the most potent disc to 
Staphylococcus aureus with 86.7% susceptibility rate, while ciprofloxacin was the least 
potent (53.3%). 
Escherichia coli was most susceptible to gentamicin and ceftriaxone (70.0%) 
respectively. Ceftriaxone was also the most potent disc for Pseudomonas aeruginosa 
(80.0%) and Proteus vulgaris (80.0%) respectively (Table 2). The resistant profile for the 
commercial discs range between 0.0% to 33.3%. Staphylococcus aureus was the most 
resistant isolates (33.3%) to ciprofloxacin discs (Table 2).  
 
Table 1 In vitro susceptibility patterns of selected clinical isolates on locally prepared antibiotic discs. 
Antibiotics   Antibiotics susceptibility in percentage (%) 
 CIP CN CFTR CAZ E 
Staphylococcus aureus  
(n=15) 
S 10(66.7) 12(80.0) 10(66.7) 13(86.7) 14(93.3) 
M 3(20.0) 3(20.0) 4(26.7) 2(13.3) 1(6.7) 
R 2(13.3) 0(0.0) 1(6.7) 0(0.0) 0(0.0) 
Escherichia coli (n=10) S 8(80.0) 9(90.0) 8(80.0) 8(80.0) NA 
M 1(10.0) 1(10.0) 1(10.0) 2(20.0) NA 
R 1(10.0) 0(0.0) 1(10.0) 0(0.0) NA 
Pseudomonas aeruginosa 
(n=10) 
S 8(80.0) 7(70.0) 9(90.0) 10(100) NA 
M 2(20.0) 3(30.0) 1(10.0) 0(0.0) NA 
R 0(0.0) 0(0.0) 0(0.0) 0(0.0) NA 
Proteus vulgaris  (n=5) S 4(80.0) 3(60.0) 5(100) 4(80.0) NA 
M 1(20.0) 0(0.0) 0(0.0) 1(20.0) NA 
R 0(0.0) 2(40.0) 0(0.0) 0(0.0) NA 
KEY  
n = number of isolates examined  
S = Sensitive  
M = moderately sensitive 
R = Resistant     
NA = Not applicable 
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Table 2 In vitro susceptibility patterns of clinical isolates on commercial antibiotics. 
Antibiotics   Antibiotics susceptibility in percentage (%) 
 CIP CN CFTR CAZ E 
Staphylococcus 
aureus 
       (n=15) 
S 8(53.3) 11(73.3) 9(60.0) 12(80.0) 13(86.7) 
M 2(13.3) 3(20.0) 3(20.0) 0(0.0) 1(6.7) 
R 5(33.3) 1(6.7) 3(20.0) 3(20.0) 1(6.7) 
Escherichia coli 
(n=10) 
S 6(60.0) 7(70.0) 7(70.0) 6(60.0) NA 
M 3(30.0) 2(20.0) 1(10.0) 4(40.0) NA 
R 1(10.0) 1(10.0) 2(20.0) 0(0.0) NA 
Pseudomonas 
aeruginosa (n=10) 
S 7(70.0) 6(60.0) 8(80.0) 8(80) NA 
M 2(20.0) 3(30.0) 2(20.0) 2(20.0) NA 
R 1(10.0) 1(10.0) 0(0.0) 0(0.0) NA 
Proteus vulgaris 
(n=5) 
S 3(60.0) 3(60.0) 4(80.0) 3(60.0) NA 
M 2(40.0) 1(20.0) 1(10.0) 1(20.0) NA 
R 0(0.0) 1(20.0) 0(0.0) 1(20.0) NA 
KEY 
n = number of isolates examined 
S = Sensitive 
M = moderately sensitive 
R = Resistant  
NA = Not applicable 
 
Table 3  Standard charts values for zone of inhibition (mm) 
 Test Organism  
Antibiotics Staphylococcus aureus Escherichia coli pseudomonas 
aeruginosa  
Proteus 
Vulgaris  
CiProfloxacin  27-35 30-40 28-35 29-35 
Gentamicin 24-32 21-28 19-24 25-30 
Ceftriaxone 19-28 25-32 23-30 24-35 
Fortum 29-33 25-31 18-22 19-30 
Erythromycin 22-30 - - - 
  Source: (CLSI, 2010b) [13]. 
 
Discussion 
The study recorded a susceptibility profile of 66.7% to 100% for locally prepared 
antibiotic discs while the range for commercial discs was 53.3% to 86.7%. The local 
antibiotic discs were more potent than commercial discs. This is in agreement with the 
work of Ayiegoro et al [14] who reported that locally prepared antibiotics are more 
potent than the commercially prepared disc. Waksman et al [15] also reported a higher 
susceptibility result using locally prepared antibiotics when compared to the 
commercially prepared antibiotics. Thus may be due to high temperature that these 
commercially prepared antibiotics are exposed to during transportation from the 
manufacturer to the end users, time of production, storage facility. 
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There was no all-round most potent commercial disc as the four clinical isolates 
displayed different susceptibility rates to the antibiotics tested. The high resistance rate 
(0.0% to 33.3%) of clinical isolates to the commercial discs may be attributed to the 
mode of storage of these antibiotic discs, prolong exposure to other environmental 
factors such as heat, moisture, sunlight as well as humidity when transported to retailers 
and the final users [11].  
This study has demonstrated a significant difference between the potency of 
locally prepared and commercial antibiotic susceptibility discs. This is not in agreement 
with the work of Epoke et al [16] in Calabar, Nigeria, who reported that discs prepared 
locally from antibiotic tablets, performed comparably with commercially obtained discs. 
The variation in results may be due to the sources of isolates tested. Epoke et al [16] 
used the American Type Culture Collection (ATTC) isolates while our isolates were 
locally sourced.      
 
Conclusion 
Locally prepared discs seem to be more effective than commercial discs. 
Antibiotic susceptibility discs can be prepared locally for routine laboratory use, this may 
indirectly reduce importation of commercial discs and the burden on foreign exchange. 
 
 
Recommendation 
There is need for constant monitoring and quality controls of susceptibility testing 
in our laboratories for the production of quality results and efficient patient care. 
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